Rchr
J-GLOBAL ID：200901048872191080   Update date: Nov. 07, 2024

Nishida Naoshi

ニシダ ナオシ | Nishida Naoshi
Affiliation and department：
Kindai University Faculty of Medicine

About Kindai University Faculty of Medicine


Homepage URL  (1)： http://www.med.kindai.ac.jp/shoukaki/index.html
Research field  (3)： Biological, health, and medical informatics ,  Genomics ,  Gastroenterology
Research keywords  (9)： data base ,  artificial Intelligence ,  Molecular Biology ,  Hepatology ,  Gastroenterology ,  Epigenetics ,  chromosome ,  tumor suppressor gene ,  Hepatocellular carcinoma
Research theme for competitive and other funds  (35)：
  • 2024 - 2027 胆道癌のドライバー変異に着目した腫瘍免疫微小環境の再構築と治療最適化
  • 2022 - 2025 免疫チェックポイント阻害剤投与に伴う急速な腫瘍増大(HPD)の発症機序の解析
  • 2021 - 2024 Analysis of immunological microenvironment of tumor and effect of smoking habits for the development of personalized medicine in liver cancer
  • 2021 - 2024 Development of AI-aided US diagnosis system for liver tumor
  • 2021 - 2024 Identification of resistant clone for the chemotherapy of hepatocellular carcinoma using cell free DNA
Show all
Papers (321)：
  • Mara Persano, Andrea Casadei-Gardini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Federico Rossari, Changhoon Yoo, Jaekyung Cheon, Fabian Finkelmeier, et al. Lenvatinib versus sorafenib second-line therapy in patients with hepatocellular carcinoma progressed to atezolizumab plus bevacizumab: a retrospective real-world study. Oncology. 2024. 1-27
  • Federico Rossari, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Changhoon Yoo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, José Presa, et al. Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study. Liver cancer. 2024. 13. 5. 522-536
  • Naoshi Nishida. Personalized Approaches to the Treatment of Hepatocellular Carcinoma Using Immune Checkpoint Inhibitors. Clinical and molecular hepatology. 2024
  • Ciro Celsa, Giuseppe Cabibbo, Claudia Angela Maria Fulgenzi, Salvatore Battaglia, Marco Enea, Bernhard Scheiner, Antonio D'Alessio, Giulia F Manfredi, Bernardo Stefanini, Naoshi Nishida, et al. Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment. Hepatology (Baltimore, Md.). 2024
  • Claudia Angela Maria Fulgenzi, Bernhard Scheiner, Antonio D'Alessio, Aman Mehan, Giulia F Manfredi, Ciro Celsa, Naoshi Nishida, Celina Ang, Thomas U Marron, Linda Wu, et al. Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction. JAMA oncology. 2024. 10. 9. 1253-1258
ｍore...
MISC (370)：
  • 西田 直生志. 【今推しの肝胆膵研究手法と疾患モデル】新規モデルによる肝胆膵研究 AIを用いた肝画像診断の最前線. 肝胆膵. 2024. 89. 2. 229-236
  • 近藤由菜, 二宮七海, 小川力, 藤田峻輔, 福家和諭, 今戸涼資, 真鍋卓嗣, 小森淳二, 神野真理, 石川雅士, et al. ABC conversion therapy with CR and drug free by re-challenge of AB therapy in a case of PD with initial AB therapy. 肝胆膵. 2024. 88. 6. 788-789
  • 西田 直生志. 【微小環境から読み解く胆膵癌】胆道癌 胆管癌における免疫逃避機序. 肝胆膵. 2024. 88. 5. 579-587
  • 西田 直生志, 工藤 正俊, 日本超音波医学会超音波画像のデータベース構築・利活用推進委員会. AIの超音波検査への応用 肝腫瘤の超音波診断を支援する人工知能の開発と社会実装. 超音波医学. 2024. 51. Suppl. S426-S426
  • 青木智子, 西田直生志, 工藤正俊. Heterogeneity of tumor immune microenvironment for primary hepatocellular carcinoma. 肝胆膵. 2024. 88. 4. 403-410
ｍore...
Books (22)：
  • Immunotherapy in Hepatocellular Carcinoma
    MDPI Books 2023 ISBN:9783036566917
  • Treatment of HCC using Atezolizumab+Bevacizumab
    2021
  • AI diagnosis for Ultrasonography
    2021 ISBN:9784274225765
  • US diagnosis for Ultrasonography
    2021 ISBN:9784274225765
  • US diagnosis for Ultrasonography
    2021 ISBN:9784274225765
ｍore...
Lectures and oral presentations  (503)：
  • Development and social implementation of artificial intelligence (AI) to assist in the ultrasound diagnosis of liver tumors - The near-future of ultrasound diagnostics with AI -
    (2024)
  • Construction of US image Database for AI Development and an Online AI Evaluation System
    (JDDW 2024 統合6(W)医療DXが切り開く消化器診療の未来 2024)
  • Comparative Analysis of Immunocyte Ratios and Prognosis in HCC Resection Specimens Using Deconvolution Methods
    (JDDW2024 ワークショップ1-5肝疾患のゲノム・エピゲノム研究の近未来 2024)
  • AI-Assisted Ultrasonic Diagnosis of Human Liver Tumors: The Role and Potential of AI in the Near-Future of Ultrasonography
    (The 51st Kansai Scientific Meeting of the Japan Society of Ultrasonics in Medicine 2024)
  • Development and Social Implementation of Artificial Intelligence to Support Diagnosis of Liver Tumors in Abdominal US
    (2024)
ｍore...
Education (2)：
  • - 1993 Kyoto University Graduate School of Medicine
  • - 1985 Osaka Medical College Faculty of Medicine Division of Medicine
Professional career (1)：
  • M.D, Ph.D. (Kyoto University Graduate School of Medicine)
Work history (6)：
  • 2021/04 - 現在 Kindai University Faculty of Medicine Professor
  • 2011/08 - 2021/03 Fuculty of Medicine Kindai University Department of Gastroenterology and Hepatology Associate Professor
  • 2006/08 - 2011/07 Kyoto University Graduate School of Medicine Department of Gastroenterology and Hepatology Assistant Professor/Lecture
  • 2004/02 - 2006/07 Baylor University Medical Center Division of Gastroenterology Reserach Associate
  • 1997/04 - 2004/01 Kyoto University Graduate School of Medicine Department of Medicine and Clinical Science Assistant Professor
Show all
Committee career (16)：
  • 2023/12 - 現在 Swiss National Science Foundation (SNSF) External Reviewer
  • 2022/11 - 現在 JSUM health committee member
  • 2022/04 - 現在 The Japan Society of Hepatology Member of COI committee
  • 2020/04 - 現在 Japan Society of Hepatology Movement for Fight against Liver Cancer, Person in Charge, Osaka Prefecture
  • 2020/04 - 現在 The Japan Society of Ultrasonics in Medicine Committee member for construction of US image database and development of US-AI
Show all
Awards (19)：
  • 2022/06 - The Japan Society of Hepatology Hepatology Research Citation Award Immune checkpoint blockade for the treatment of human hepatocellular carcinoma
  • 2021/04 - SRF Research Grant Analysis of immunological microenvironment of liver cancer
  • 2020/04 - National Institute of Informatics ROIS NII Open Collaborative Research 2020 Artificial intelligence for prediction of outcome after chemotherapy in patients with hepatocellular carcinoma
  • 2017/04 - 公益財団法人SRF財団 一般研究助成
  • 2012/06 - 財団法人ひと・健康・未来研究財団 研究助成(医学分野)
Show all
Association Membership(s) (10)：
米国消化器病学会 ,  日本高齢消化器病学会 ,  THE JAPAN SOCIETY FOR CLINICAL IMMUNOLOGY ,  THE JAPAN SOCIETY OF ULTRASONICS IN MEDICINE ,  JAPAN GASTROENTEROLOGICAL ENDOSCOPY SOCIETY ,  日本分子生物学会 ,  日本癌学会 ,  日本消化器病学会 ,  日本肝臓学会 ,  日本内科学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM